230 related articles for article (PubMed ID: 17631933)
1. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system.
Argyris EG; Acheampong E; Wang F; Huang J; Chen K; Mukhtar M; Zhang H
Virology; 2007 Oct; 367(2):440-51. PubMed ID: 17631933
[TBL] [Abstract][Full Text] [Related]
2. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells.
Wang FX; Huang J; Zhang H; Ma X; Zhang H
J Gen Virol; 2008 Mar; 89(Pt 3):722-730. PubMed ID: 18272764
[TBL] [Abstract][Full Text] [Related]
4. [Cellular restriction factors that inhibit human immunodeficiency virus replication: new strategies in antiretroviral therapy].
Moreno-Valencia Y; Alvarez-García LX; Vázquez-Pérez JA
Rev Invest Clin; 2014; 66(4):359-68. PubMed ID: 25695302
[TBL] [Abstract][Full Text] [Related]
5. IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells.
Mohanram V; Sköld AE; Bächle SM; Pathak SK; Spetz AL
J Immunol; 2013 Apr; 190(7):3346-53. PubMed ID: 23427247
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Gag-virus-like particles inhibit HIV-1 replication in dendritic cells and T cells through IFN-α-dependent upregulation of APOBEC3G and 3F.
Chang MO; Suzuki T; Yamamoto N; Watanabe M; Takaku H
J Innate Immun; 2012; 4(5-6):579-90. PubMed ID: 22739040
[TBL] [Abstract][Full Text] [Related]
7. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
[TBL] [Abstract][Full Text] [Related]
8. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.
Lavender KJ; Gibbert K; Peterson KE; Van Dis E; Francois S; Woods T; Messer RJ; Gawanbacht A; Müller JA; Münch J; Phillips K; Race B; Harper MS; Guo K; Lee EJ; Trilling M; Hengel H; Piehler J; Verheyen J; Wilson CC; Santiago ML; Hasenkrug KJ; Dittmer U
J Virol; 2016 Jul; 90(13):6001-6013. PubMed ID: 27099312
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G & HTLV-1: inhibition without deamination.
Strebel K
Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
[TBL] [Abstract][Full Text] [Related]
10. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R; Spadari S; Maga G
Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
[TBL] [Abstract][Full Text] [Related]
11. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
Jost S; Turelli P; Mangeat B; Protzer U; Trono D
J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
[TBL] [Abstract][Full Text] [Related]
12. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
[TBL] [Abstract][Full Text] [Related]
13. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
[TBL] [Abstract][Full Text] [Related]
14. Enhancing immunity to HIV through APOBEC.
Harris RS
Nat Biotechnol; 2008 Oct; 26(10):1089-90. PubMed ID: 18846074
[No Abstract] [Full Text] [Related]
15. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
16. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
Zheng YH; Irwin D; Kurosu T; Tokunaga K; Sata T; Peterlin BM
J Virol; 2004 Jun; 78(11):6073-6. PubMed ID: 15141007
[TBL] [Abstract][Full Text] [Related]
17. Arsenic modulates APOBEC3G-mediated restriction to HIV-1 infection in myeloid dendritic cells.
Stalder R; Blanchet F; Mangeat B; Piguet V
J Leukoc Biol; 2010 Dec; 88(6):1251-8. PubMed ID: 20807705
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Kanari Y; Magri G; Trabattoni D; Naddeo V; Lopalco L; Clivio A; Cesana E; Fasano F; Bergamaschi C; Mazzotta F; Miyazawa M; Clerici M
J Infect Dis; 2007 Apr; 195(7):960-4. PubMed ID: 17330785
[TBL] [Abstract][Full Text] [Related]
19. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
[TBL] [Abstract][Full Text] [Related]
20. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes.
Tanaka Y; Marusawa H; Seno H; Matsumoto Y; Ueda Y; Kodama Y; Endo Y; Yamauchi J; Matsumoto T; Takaori-Kondo A; Ikai I; Chiba T
Biochem Biophys Res Commun; 2006 Mar; 341(2):314-9. PubMed ID: 16426578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
